NASDAQ: ALXN       Alexion Pharm Inc
Last Price Today's Change   Day's Range   Trading Volume
121.525   +1.985 (1.66%)  119.47 - 121.74  317,435


Avg Volume (4 weeks):0
4 Weeks Range:113.42 - 122.93
52 Weeks Range:109.12 - 158.08
Average Price Target: 208.00
Price Target Upside/Downside: +86.475


No recent Headlines for this stock.

Business Background

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.

  Be the first to like this.


4216  1983  855  1269 

Top 10 Active Counters
 JNUG 4.645-0.605 
 BAC 24.12+0.49 
 NUGT 8.54-0.82 
 ABX 17.43-1.61 
 AKS 7.06-0.06 
 SPY 238.73+1.56 
 APFH 40.26+3.59 
 FCX 13.13+0.90 
 CYTR 0.812-0.018 
 XLF 23.98+0.30 
Partners & Brokers